Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
≥1,000 26 32 26 32 O
/ 32 33 32 33 I-lower_bound
mm3 33 36 33 36 I-lower_bound
without 37 44 37 44 O
growth 45 51 45 51 O
factor 52 58 52 58 O
use 59 62 59 62 O
≤ 63 64 63 64 O
7 65 66 65 66 B-upper_bound
days 67 71 67 71 I-upper_bound
prior 72 77 72 77 I-upper_bound
to 78 80 78 80 O
treatment 81 90 81 90 B-treatment
( 91 92 91 92 O
cycle 92 97 92 97 O
1 98 99 98 99 O
day 100 103 100 103 O
1 104 105 104 105 O
, 105 106 105 106 O
C1D1 107 111 107 111 O
) 111 112 111 112 O

Active 0 6 113 119 B-chronic_disease
bacterial 7 16 120 129 I-chronic_disease
, 16 17 129 130 I-chronic_disease
fungal 18 24 131 137 I-chronic_disease
or 25 27 138 140 I-chronic_disease
viral 28 33 141 146 I-chronic_disease
infection 34 43 147 156 I-chronic_disease
including 44 53 157 166 O
hepatitis 54 63 167 176 B-chronic_disease
B 64 65 177 178 I-chronic_disease
( 66 67 179 180 I-chronic_disease
HBV 67 70 180 183 I-chronic_disease
) 70 71 183 184 I-chronic_disease
, 71 72 184 185 O
hepatitis 73 82 186 195 B-chronic_disease
C 83 84 196 197 I-chronic_disease
( 85 86 198 199 I-chronic_disease
HCV 86 89 199 202 I-chronic_disease
) 89 90 202 203 I-chronic_disease

All 0 3 204 207 O
previous 4 12 208 216 O
therapies 13 22 217 226 O
for 23 26 227 230 O
cancer 27 33 231 237 B-cancer
, 33 34 237 238 O
including 35 44 239 248 O
radiotherapy 45 57 249 261 B-treatment
, 57 58 261 262 O
major 59 64 263 268 B-treatment
surgery 65 72 269 276 I-treatment
and 73 76 277 280 O
investigational 77 92 281 296 B-treatment
therapies 93 102 297 306 I-treatment
discontinued 103 115 307 319 O
for 116 119 320 323 O
≥ 120 121 324 325 O
14 122 124 326 328 B-lower_bound
days 125 129 329 333 I-lower_bound
( 130 131 334 335 O
≥ 131 132 335 336 O
28 133 135 337 339 B-lower_bound
days 136 140 340 344 I-lower_bound
for 141 144 345 348 O
mitomycin 145 154 349 358 B-treatment
C 155 156 359 360 I-treatment
or 157 159 361 363 O
nitrosoureas 160 172 364 376 B-treatment
) 172 173 376 377 O
before 174 180 378 384 O
study 181 186 385 390 O
entry 187 192 391 396 O

Any 0 3 397 400 O
of 4 6 401 403 O
the 7 10 404 407 O
following 11 20 408 417 O
in 21 23 418 420 O
the 24 27 421 424 O
previous 28 36 425 433 B-upper_bound
6 37 38 434 435 I-upper_bound
months 39 45 436 442 I-upper_bound
: 45 46 442 443 O
myocardial 47 57 444 454 B-chronic_disease
infarction 58 68 455 465 I-chronic_disease
, 68 69 465 466 O
severe 70 76 467 473 O
/ 76 77 473 474 O
unstable 77 85 474 482 B-chronic_disease
angina 86 92 483 489 I-chronic_disease
, 92 93 489 490 O
coronary 94 102 491 499 B-treatment
/ 102 103 499 500 I-treatment
peripheral 103 113 500 510 I-treatment
artery 114 120 511 517 I-treatment
bypass 121 127 518 524 I-treatment
graft 128 133 525 530 I-treatment
, 133 134 530 531 O
symptomatic 135 146 532 543 O
congestive 147 157 544 554 B-chronic_disease
heart 158 163 555 560 I-chronic_disease
failure 164 171 561 568 I-chronic_disease
, 171 172 568 569 O
cerebrovascular 173 188 570 585 B-chronic_disease
accident 189 197 586 594 I-chronic_disease
, 197 198 594 595 O
transient 199 208 596 605 B-chronic_disease
ischemic 209 217 606 614 I-chronic_disease
attack 218 224 615 621 I-chronic_disease
or 225 227 622 624 O
symptomatic 228 239 625 636 O
pulmonary 240 249 637 646 B-chronic_disease
embolism 250 258 647 655 I-chronic_disease

ECOG 0 4 656 660 B-clinical_variable
performance 5 16 661 672 I-clinical_variable
status 17 23 673 679 I-clinical_variable
≤ 24 25 680 681 O
1 26 27 682 683 B-upper_bound

Female 0 6 684 690 B-gender
patients 7 15 691 699 I-gender
must 16 20 700 704 O
be 21 23 705 707 O
surgically 24 34 708 718 O
sterile 35 42 719 726 O
or 43 45 727 729 O
be 46 48 730 732 O
postmenopausal 49 63 733 747 O
, 63 64 747 748 O
or 65 67 749 751 O
must 68 72 752 756 O
agree 73 78 757 762 B-contraception_consent
to 79 81 763 765 I-contraception_consent
use 82 85 766 769 I-contraception_consent
effective 86 95 770 779 I-contraception_consent
contraception 96 109 780 793 I-contraception_consent
during 110 116 794 800 O
the 117 120 801 804 O
period 121 127 805 811 O
of 128 130 812 814 O
the 131 134 815 818 O
trial 135 140 819 824 O
and 141 144 825 828 O
for 145 148 829 832 O
at 149 151 833 835 O
least 152 157 836 841 O
90 158 160 842 844 B-lower_bound
days 161 165 845 849 I-lower_bound
after 166 171 850 855 O
completion 172 182 856 866 O
of 183 185 867 869 O
treatment 186 195 870 879 B-treatment

Hemoglobin 0 10 880 890 B-clinical_variable
> 11 12 891 892 O
8.0 12 15 892 895 B-lower_bound
mg 16 18 896 898 I-lower_bound
/ 18 19 898 899 I-lower_bound
dL 19 21 899 901 I-lower_bound
without 22 29 902 909 O
red 30 33 910 913 B-clinical_variable
blood 34 39 914 919 I-clinical_variable
cell 40 44 920 924 I-clinical_variable
transfusion 45 56 925 936 I-clinical_variable
≤ 57 58 937 938 O
3 59 60 939 940 B-upper_bound
days 61 65 941 945 I-upper_bound
prior 66 71 946 951 I-upper_bound
to 72 74 952 954 O
C1D1 75 79 955 959 O

Known 0 5 960 965 O
human 6 11 966 971 B-chronic_disease
immunodeficiency 12 28 972 988 I-chronic_disease
virus 29 34 989 994 I-chronic_disease
( 35 36 995 996 I-chronic_disease
HIV 36 39 996 999 I-chronic_disease
) 39 40 999 1000 I-chronic_disease
or 41 43 1001 1003 O
acquired 44 52 1004 1012 B-chronic_disease
immunodeficiency 53 69 1013 1029 I-chronic_disease
syndrome 70 78 1030 1038 I-chronic_disease
( 79 80 1039 1040 I-chronic_disease
AIDS)-related 80 93 1040 1053 I-chronic_disease
illness 94 101 1054 1061 O
that 102 106 1062 1066 O
is 107 109 1067 1069 O
not 110 113 1070 1073 O
well 114 118 1074 1078 O
controlled 119 129 1079 1089 O

Male 0 4 1090 1094 B-gender
patients 5 13 1095 1103 I-gender
must 14 18 1104 1108 O
be 19 21 1109 1111 O
surgically 22 32 1112 1122 O
sterile 33 40 1123 1130 O
or 41 43 1131 1133 O
must 44 48 1134 1138 O
agree 49 54 1139 1144 B-contraception_consent
to 55 57 1145 1147 I-contraception_consent
use 58 61 1148 1151 I-contraception_consent
effective 62 71 1152 1161 I-contraception_consent
contraception 72 85 1162 1175 I-contraception_consent
during 86 92 1176 1182 O
the 93 96 1183 1186 O
period 97 103 1187 1193 O
of 104 106 1194 1196 O
the 107 110 1197 1200 O
trial 111 116 1201 1206 O
and 117 120 1207 1210 O
for 121 124 1211 1214 O
at 125 127 1215 1217 O
least 128 133 1218 1223 O
90 134 136 1224 1226 B-lower_bound
days 137 141 1227 1231 I-lower_bound
after 142 147 1232 1237 O
completion 148 158 1238 1248 O
of 159 161 1249 1251 O
treatment 162 171 1252 1261 O

Measurable 0 10 1262 1272 O
disease 11 18 1273 1280 O
M 19 20 1281 1282 O
protein 21 28 1283 1290 O
component 29 38 1291 1300 O
in 39 41 1301 1303 O
serum 42 47 1304 1309 B-clinical_variable
( 48 49 1310 1311 O
at 49 51 1311 1313 O
least 52 57 1314 1319 O
0.5 58 61 1320 1323 B-lower_bound
g 62 63 1324 1325 I-lower_bound
/ 63 64 1325 1326 I-lower_bound
dL 64 66 1326 1328 I-lower_bound
) 66 67 1328 1329 O
and/or 68 74 1330 1336 O
urine 75 80 1337 1342 B-clinical_variable
( 81 82 1343 1344 O
if 82 84 1344 1346 O
present 85 92 1347 1354 O
) 92 93 1354 1355 O
( 94 95 1356 1357 O
> 95 96 1357 1358 O
= 96 97 1358 1359 O
0.2 97 100 1359 1362 B-lower_bound
g 101 102 1363 1364 I-lower_bound
excreted 103 111 1365 1373 O
in 112 114 1374 1376 O
a 115 116 1377 1378 O
24 117 119 1379 1381 O
hour 120 124 1382 1386 O
collection 125 135 1387 1397 O
sample 136 142 1398 1404 O
) 142 143 1404 1405 O

Patients 0 8 1406 1414 O
must 9 13 1415 1419 O
be 14 16 1420 1422 O
refractory 17 27 1423 1433 O
to 28 30 1434 1436 O
, 30 31 1436 1437 O
or 32 34 1438 1440 O
not 35 38 1441 1444 O
a 39 40 1445 1446 O
candidate 41 50 1447 1456 O
for 51 54 1457 1460 O
, 54 55 1460 1461 O
established 56 67 1462 1473 O
therapy 68 75 1474 1481 B-treatment
known 76 81 1482 1487 O
to 82 84 1488 1490 O
provide 85 92 1491 1498 O
clinical 93 101 1499 1507 O
benefit 102 109 1508 1515 O
for 110 113 1516 1519 O
their 114 119 1520 1525 O
malignancy 120 130 1526 1536 B-cancer

Platelets 0 9 1537 1546 B-clinical_variable
≥75,000 10 17 1547 1554 O
/ 17 18 1554 1555 I-lower_bound
mm3 18 21 1555 1558 I-lower_bound
without 22 29 1559 1566 O
platelet 30 38 1567 1575 B-clinical_variable
transfusion 39 50 1576 1587 I-clinical_variable
≤ 51 52 1588 1589 O
3 53 54 1590 1591 B-upper_bound
days 55 59 1592 1596 I-upper_bound
prior 60 65 1597 1602 I-upper_bound
to 66 68 1603 1605 O
C1D1 69 73 1606 1610 B-treatment

Serum 0 5 1611 1616 B-clinical_variable
creatinine 6 16 1617 1627 I-clinical_variable
≤ 17 18 1628 1629 O
1.5 19 22 1630 1633 B-upper_bound
X 23 24 1634 1635 I-upper_bound
ULN 25 28 1636 1639 I-upper_bound
( 29 30 1640 1641 O
OR 30 32 1641 1643 O
creatinine 33 43 1644 1654 B-clinical_variable
clearance 44 53 1655 1664 I-clinical_variable
≥ 54 55 1665 1666 O
60 56 58 1667 1669 B-lower_bound
mL 59 61 1670 1672 I-lower_bound
/ 61 62 1672 1673 I-lower_bound
min/1.73 62 70 1673 1681 I-lower_bound
m2 71 73 1682 1684 I-lower_bound
) 73 74 1684 1685 O

Serum 0 5 1686 1691 B-pregnancy
or 6 8 1692 1694 I-pregnancy
urine 9 14 1695 1700 I-pregnancy
pregnancy 15 24 1701 1710 I-pregnancy
test 25 29 1711 1715 O
( 30 31 1716 1717 O
for 31 34 1717 1720 O
females 35 42 1721 1728 B-gender
of 43 45 1729 1731 O
childbearing 46 58 1732 1744 O
potential 59 68 1745 1754 O
) 68 69 1754 1755 O
negative 70 78 1756 1764 O
≤7 79 81 1765 1767 O
days 82 86 1768 1772 I-upper_bound
of 87 89 1773 1775 O
starting 90 98 1776 1784 O
treatment 99 108 1785 1794 O

Solitary 0 8 1795 1803 O
bone 9 13 1804 1808 O
or 14 16 1809 1811 O
solitary 17 25 1812 1820 O
extramedullary 26 40 1821 1835 O
plasmacytoma 41 53 1836 1848 O
as 54 56 1849 1851 O
the 57 60 1852 1855 O
only 61 65 1856 1860 O
evidence 66 74 1861 1869 O
of 75 77 1870 1872 O
plasma 78 84 1873 1879 B-chronic_disease
cell 85 89 1880 1884 I-chronic_disease
dyscrasia 90 99 1885 1894 I-chronic_disease

Subjects 0 8 1895 1903 O
with 9 13 1904 1908 O
serum 14 19 1909 1914 B-clinical_variable
calcium 20 27 1915 1922 I-clinical_variable
( 28 29 1923 1924 O
corrected 29 38 1924 1933 O
for 39 42 1934 1937 O
albumin 43 50 1938 1945 O
) 50 51 1945 1946 O
≥ 52 53 1947 1948 O
12 54 56 1949 1951 B-lower_bound
mg 57 59 1952 1954 I-lower_bound
/ 59 60 1954 1955 I-lower_bound
dL 60 62 1955 1957 I-lower_bound

Total 0 5 1958 1963 B-clinical_variable
serum 6 11 1964 1969 I-clinical_variable
bilirubin 12 21 1970 1979 I-clinical_variable
< 22 23 1980 1981 O
1.5 23 26 1981 1984 B-upper_bound
X 27 28 1985 1986 I-upper_bound
upper 29 34 1987 1992 I-upper_bound
limit 35 40 1993 1998 I-upper_bound
of 41 43 1999 2001 I-upper_bound
normal 44 50 2002 2008 I-upper_bound
( 51 52 2009 2010 I-upper_bound
ULN 52 55 2010 2013 I-upper_bound
) 55 56 2013 2014 I-upper_bound

all 0 3 2015 2018 O
acute 4 9 2019 2024 O
effects 10 17 2025 2032 O
of 18 20 2033 2035 O
any 21 24 2036 2039 O
prior 25 30 2040 2045 B-treatment
therapy 31 38 2046 2053 I-treatment
resolved 39 47 2054 2062 O
to 48 50 2063 2065 O
baseline 51 59 2066 2074 O
severity 60 68 2075 2083 O
or 69 71 2084 2086 O
Grade 72 77 2087 2092 O
≤ 78 79 2093 2094 O
1 80 81 2095 2096 B-upper_bound
Common 82 88 2097 2103 O
Terminology 89 100 2104 2115 O
Criteria 101 109 2116 2124 O
for 110 113 2125 2128 O
Adverse 114 121 2129 2136 O
Events 122 128 2137 2143 O
( 129 130 2144 2145 O
CTCAE 130 135 2145 2150 O
v4.03 136 141 2151 2156 O
) 141 142 2156 2157 O
, 142 143 2157 2158 O
except 144 150 2159 2165 O
alopecia 151 159 2166 2174 B-chronic_disease
or 160 162 2175 2177 O
parameters 163 173 2178 2188 O
defined 174 181 2189 2196 O
in 182 184 2197 2199 O
this 185 189 2200 2204 O
eligibility 190 201 2205 2216 O
list 202 206 2217 2221 O

